Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7673092 | 0.74 | CYP1A2 (0.41) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL1583185 | 0.72 | CYP1A2 (0.56) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL236516 | 0.72 | CYP1A2 (1.00) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL65000 | 0.71 | CYP1A2 (0.53) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL2139630 | 0.71 | — | — | |
| SCHEMBL7673166 | 0.70 | CYP1A2 (0.38) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL7670475 | 0.69 | CYP1A2 (0.37) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL7931276 | 0.69 | CYP1A2 (0.46) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL8021435 | 0.68 | CYP1A2 (0.50) | CYP1A2MAPK1CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL2139422 | 0.68 | CYP1A2 (0.50) | CYP1A2MAPK1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | disclosed |